Fails 2 of 8 criteria. S3, pharmacy identification: No filling pharmacy is named. The how it works page refers to licensed pharmacy partners in the United States, and the terms and disclaimers to the dispensing pharmacy and the platform's pharmacy network. 1 more criterion also fails; see the table below.
At a glance
CaliberRxTelehealth service
6/8criteria passed
Price
Semaglutide and tirzepatide from $199 a month; its disclaimers say medication is billed separately
Sells
compounded semaglutide, compounded tirzepatide, NAD+, and 3 more
Telehealth service. Passes 6 of 8 criteria. Recorded against Standard v1.1.
A Dallas-based telehealth management company selling compounded semaglutide and tirzepatide memberships, compounded NAD+ and a line of sexual health treatments, with care from an independent provider group. Care starts with an online medical intake, and no pharmacy is named.
The evidence behind each disposition in the table above, where it appears, and its date.
S1PASSA licensed provider reviews each intake and decides whether a compounded GLP-1 medication is appropriate, and the terms and telehealth consent say care is given by an independent provider group whose clinicians use their own clinical judgment.Source: CaliberRx's how it works page; CaliberRx's telehealth consent; CaliberRx's terms of service page.
S2PASSThe how it works page says care starts with a medical intake of health history, medications and allergies that a licensed provider reviews before any prescription, and no page describes a payment step before that intake.Source: CaliberRx's how it works page; CaliberRx's website; CaliberRx's payment and billing consent.
S3FAILNo filling pharmacy is named. The how it works page refers to licensed pharmacy partners in the United States, and the terms and disclaimers to the dispensing pharmacy and the platform's pharmacy network.Source: CaliberRx's how it works page; CaliberRx's terms of service page; CaliberRx's program disclaimers page.
S4PASSThe program disclaimers carry a compounded product notice stating that compounded preparations are not evaluated or approved by the FDA for safety, efficacy or quality, and the semaglutide section points to it.Source: CaliberRx's program disclaimers page; CaliberRx's website.
S5FAILNo certificate of analysis or lot document is published on the treatment pages, the program disclaimers, the terms or the privacy policy.Source: CaliberRx's treatments page; CaliberRx's program disclaimers page; CaliberRx's terms of service page.
S6PASSCaliberRx LLC at 6601 Hillcrest Ave., Suite E, Dallas, Texas 75205, printed in the footer of every page and on each legal page. The terms name Texas law.Source: CaliberRx's website; CaliberRx's terms of service page; CaliberRx's privacy policy.
S7PASSSemaglutide and tirzepatide are each listed from $199 a month. The program disclaimers say the prices shown cover only the membership and coordination services, with the medication billed separately by the dispensing pharmacy and consultations by the provider group, and the billing consent adds a $30 fee for a missed appointment.Source: CaliberRx's website; CaliberRx's program disclaimers page; CaliberRx's payment and billing consent.
S8PASSNo FDA warning letter names CaliberRx or CaliberRx LLC, and no action has halted the business.Source: FDA warning-letter index.
Products shown on the seller's own pages at the recorded date: compounded semaglutide, compounded tirzepatide, NAD+, sildenafil, tadalafil, compounded sexual health blends.
Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.